BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 30382016)

  • 1. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
    Thwaites GE; Scarborough M; Szubert A; Saramago Goncalves P; Soares M; Bostock J; Nsutebu E; Tilley R; Cunningham R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS
    Health Technol Assess; 2018 Oct; 22(59):1-148. PubMed ID: 30382016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
    Thwaites GE; Scarborough M; Szubert A; Nsutebu E; Tilley R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS;
    Lancet; 2018 Feb; 391(10121):668-678. PubMed ID: 29249276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.
    Thwaites G; Auckland C; Barlow G; Cunningham R; Davies G; Edgeworth J; Greig J; Hopkins S; Jeyaratnam D; Jenkins N; Llewelyn M; Meisner S; Nsutebu E; Planche T; Read RC; Scarborough M; Soares M; Tilley R; Török ME; Williams J; Wilson P; Wyllie S; Walker AS;
    Trials; 2012 Dec; 13():241. PubMed ID: 23249501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
    Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Whittaker AC; Hawkey P; Low E; Dunn JA
    Health Technol Assess; 2019 Nov; 23(62):1-94. PubMed ID: 31690402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of recurrence, early treatment failure and death from Staphylococcus aureus bacteraemia: Observational analyses within the ARREST trial.
    Szubert A; Bailey SL; Cooke GS; Peto T; Llewelyn MJ; Edgeworth JD; Walker AS; Thwaites GE;
    J Infect; 2019 Oct; 79(4):332-340. PubMed ID: 31398375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
    Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH
    Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.
    Scarborough M; Li HK; Rombach I; Zambellas R; Walker AS; McNally M; Atkins B; Kümin M; Lipsky BA; Hughes H; Bose D; Warren S; Mack D; Folb J; Moore E; Jenkins N; Hopkins S; Seaton RA; Hemsley C; Sandoe J; Aggarwal I; Ellis S; Sutherland R; Geue C; McMeekin N; Scarborough C; Paul J; Cooke G; Bostock J; Khatamzas E; Wong N; Brent A; Lomas J; Matthews P; Wangrangsimakul T; Gundle R; Rogers M; Taylor A; Thwaites GE; Bejon P
    Health Technol Assess; 2019 Aug; 23(38):1-92. PubMed ID: 31373271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT.
    Mallucci CL; Jenkinson MD; Conroy EJ; Hartley JC; Brown M; Moitt T; Dalton J; Kearns T; Griffiths MJ; Culeddu G; Solomon T; Hughes D; Gamble C;
    Health Technol Assess; 2020 Mar; 24(17):1-114. PubMed ID: 32238262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
    Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
    Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
    Webb NJ; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Wheatley K; Ives NJ
    Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaesthetic-analgesic ear drops to reduce antibiotic consumption in children with acute otitis media: the CEDAR RCT.
    Hay AD; Downing H; Francis NA; Young GJ; Clement C; Harris SD; Ahern A; Schofield B; Thomas TE; Horwood J; Blair PS; Hollingworth W; Wilson V; Metcalfe C; Stoddart P; Nunez D; Lyttle MD; Little P; Moore MV
    Health Technol Assess; 2019 Jul; 23(34):1-48. PubMed ID: 31304912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions to reduce Staphylococcus aureus in the management of eczema.
    George SM; Karanovic S; Harrison DA; Rani A; Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study.
    Forsblom E; Ruotsalainen E; Järvinen A
    PLoS One; 2015; 10(4):e0122824. PubMed ID: 25874546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
    Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
    Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCT.
    Pickard R; Chadwick T; Oluboyede Y; Brennand C; von Wilamowitz-Moellendorff A; McClurg D; Wilkinson J; Ternent L; Fisher H; Walton K; McColl E; Vale L; Wood R; Abdel-Fattah M; Hilton P; Fader M; Harrison S; Larcombe J; Little P; Timoney A; N'Dow J; Armstrong H; Morris N; Walker K; Thiruchelvam N
    Health Technol Assess; 2018 May; 22(24):1-102. PubMed ID: 29766842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
    Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
    Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.
    Harding C; Chadwick T; Homer T; Lecouturier J; Mossop H; Carnell S; King W; Abouhajar A; Vale L; Watson G; Forbes R; Currer S; Pickard R; Eardley I; Pearce I; Thiruchelvam N; Guerrero K; Walton K; Hussain Z; Lazarowicz H; Ali A
    Health Technol Assess; 2022 May; 26(23):1-172. PubMed ID: 35535708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT.
    Barratt S; Bielicki JA; Dunn D; Faust SN; Finn A; Harper L; Jackson P; Lyttle MD; Powell CV; Rogers L; Roland D; Stöhr W; Sturgeon K; Vitale E; Wan M; Gibb DM; Sharland M
    Health Technol Assess; 2021 Nov; 25(60):1-72. PubMed ID: 34738518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
    Ruotsalainen E; Järvinen A; Koivula I; Kauma H; Rintala E; Lumio J; Kotilainen P; Vaara M; Nikoskelainen J; Valtonen V;
    J Intern Med; 2006 Feb; 259(2):179-90. PubMed ID: 16420547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up.
    Walsh TS; Stanworth S; Boyd J; Hope D; Hemmatapour S; Burrows H; Campbell H; Pizzo E; Swart N; Morris S
    Health Technol Assess; 2017 Oct; 21(62):1-118. PubMed ID: 29067906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.